Serpina3n administration in an MS mouse model reduced disease severity and reduced axonal and neuronal injury [192] while granzyme B pharmacological inhibition with VTI-1002 ameliorated disease in 3 murine models of autoimmune blistering disease [193]. The gene discussed is GZMB; the disease is myeloid sarcoma.